Artificial intelligence news.
Straight from the original announcements.

Sino Biological launches 4RISE wet-lab service for AI-designed binders

November 13, 2026, 17:25By the AI News Bites Editorial TeamSource: PR Newswire
Sino Biological launches 4RISE wet-lab service for AI-designed binders
Image: PR Newswire

Sino Biological has launched 4RISE™, a high-throughput wet-lab validation service for AI-designed protein binders. The company says the service can deliver cell-free protein expression in 3 hours and AI-ready binding data in as few as 3 days.

Key points
  • 4RISE™ is a high-throughput wet-lab validation service for AI-designed protein binders.
  • XPressMAX™ supports cell-free protein expression in as few as 3 hours.
  • The service provides AI-ready binding data and sequencing in as few as 3 days.
  • Structured binding data can be accessed in real time through an API.
  • 4RISE™ includes more than 20 developability assays and more than 1000 protein bioactivity assays.

A faster validation workflow for AI-designed proteins

AI-designed protein binders require wet-lab validation to confirm whether they bind to their intended targets. Sino Biological, Inc., a recombinant technology company listed on the Shenzhen Stock Exchange as 301047.SZ, said 4RISE™ is designed to help life sciences researchers working with AI move from computational designs to experimental evidence more quickly.

The service combines Sino Biological's XPressMAX™ Cell-Free Protein Synthesis platform with high-throughput binding technologies. The company says XPressMAX™ can produce recombinant proteins in as few as 3 hours, with expression success rates above 99% in established workflows.

The platform supports the synthesis of miniproteins, VHH, scFv, Fab, enzymes and cytokines. Sino Biological says this allows researchers to test AI-designed protein candidates sooner and use the results to guide further design iterations.

Binding data delivered through an API

4RISE™ uses high-throughput SPR technologies from Carterra, Biacore SPR and Octet BLI for binding screening, kinetic analysis and affinity determination. Combined with cell-free protein synthesis, the workflow provides binding data and sequencing that are ready for AI use in as few as 3 days, according to Sino Biological.

The resulting binding data are structured and available in real time through an API. That access is intended to support data retrieval for follow-up research and analysis, allowing AI-focused teams to incorporate experimental results into their workflows.

Sino Biological says 4RISE™ can support different candidate formats and validation requirements through four screening and characterization workflows. Rapid Hit Discovery identifies miniproteins and VHH with positive binding by screening crude supernatants. Comparative binder screening evaluates purified candidates under standardized conditions to support candidate prioritization.

Four screening services and broader candidate testing

The affinity and kinetics characterization service provides quantitative binding information for lead selection. A specialized binder expression and validation service supports different binder formats through tailored binding analyses and mammalian expression.

Beyond binding measurements, 4RISE™ provides more than 20 developability assays, more than 1000 protein bioactivity assays and more than 10 cell-based functional assays. Sino Biological presents these services as a way to assess candidates more broadly and optimize their designs after initial binding tests.

Supporting AI-driven drug discovery programs

Sino Biological says it works with AI companies on wet-lab validation for AI-designed antibody discovery, de novo binder design and computational protein engineering. The company also says 4RISE™ wet-lab validation has supported studies published in Science, Nature Communications, Scientific Reports and other high-impact journals.

Dr. Rob Burgess, chief commercial officer of Sino Biological US, said the company's integrated capabilities provide researchers with data to evaluate candidates quickly, shorten design cycles and move promising discoveries toward real-world applications. For AI-driven drug discovery teams, the service's stated value is the combination of rapid expression, structured experimental data and API access in a workflow focused on protein-binder validation.

Related news

Sino Biological launches 4RISE wet-lab service for AI-designed binders
Products and toolsNovember 13, 2026, 17:24

Sino Biological launches 4RISE wet-lab service for AI-designed binders

Sino Biological has launched 4RISE™, a high-throughput wet-lab validation service for AI-designed protein binders. The company says the service combines cell-free…

Sino Biological Launches 4RISE Wet-Lab Services for AI-Designed Binders
Products and toolsNovember 13, 2026, 16:05

Sino Biological Launches 4RISE Wet-Lab Services for AI-Designed Binders

Sino Biological has launched 4RISE™, a high-throughput wet-lab validation service for AI-designed protein binders. The company says the workflow can provide cell-free…

Sino Biological Launches 4RISE Services for AI-Designed Protein Binders
Products and toolsNovember 13, 2026, 16:05

Sino Biological Launches 4RISE Services for AI-Designed Protein Binders

Sino Biological has launched 4RISE™, a high-throughput wet-lab validation service for AI-designed protein binders. The company says the workflow combines 3-hour…